- Home
- Publications
- Publication Search
- Publication Details
Title
Factor VIII therapy for hemophilia A: current and future issues
Authors
Keywords
-
Journal
Expert Review of Hematology
Volume 7, Issue 3, Pages 373-385
Publisher
Informa UK Limited
Online
2014-04-10
DOI
10.1586/17474086.2014.899896
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A
- (2013) M. D. Carcao et al. BLOOD
- Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
- (2013) K. Fischer et al. BLOOD
- Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
- (2013) S. C. Gouw et al. BLOOD
- von Willebrand factor contributes to longer half-life of PEGylated factor VIIIin vivo
- (2013) L. Tang et al. HAEMOPHILIA
- Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A
- (2013) A. Tiede et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Factor VIII Products and Inhibitor Development in Severe Hemophilia A
- (2013) Samantha C. Gouw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Innovative coagulation factors: albumin fusion technology and recombinant single-chain factor VIII
- (2013) Stefan Schulte THROMBOSIS RESEARCH
- Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients
- (2012) J. S. Powell et al. BLOOD
- Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients
- (2012) E. Santagostino et al. BLOOD
- F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
- (2012) S. C. Gouw et al. BLOOD
- Investigation of disease-associated factors in haemophilia A patients without detectable mutations
- (2012) C. HALLDÉN et al. HAEMOPHILIA
- Tertiary prophylaxis in adults: is there a rationale?
- (2012) A. Gringeri et al. HAEMOPHILIA
- F8haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
- (2012) J. Schwarz et al. HAEMOPHILIA
- A survey of the outcome of prophylaxis, on-demand treatment or combined treatment in 18-35-year old men with severe haemophilia in six countries
- (2012) D. Noone et al. HAEMOPHILIA
- Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey
- (2012) S. ZAPPA et al. HAEMOPHILIA
- Pharmacokinetics and pharmacodynamics of turoctocog alfa and N8-GP in haemophilia A dogs
- (2012) H. Agersø et al. HAEMOPHILIA
- Guidelines for the management of hemophilia
- (2012) A. Srivastava et al. HAEMOPHILIA
- WFH: Closing the global gap - achieving optimal care
- (2012) MARK W. SKINNER HAEMOPHILIA
- Identification of a third rearrangement at Xq28 that causes severe hemophilia A as a result of homologous recombination between inverted repeats
- (2012) B. PEZESHKPOOR et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada
- (2012) J. KRAFT et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight
- (2011) S. Bjorkman et al. BLOOD
- Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
- (2011) A. D. Shapiro et al. BLOOD
- Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B
- (2011) C. Negrier et al. BLOOD
- Cumulative inhibitor incidence in previously untreated patients with severe hemophilia A treated with plasma-derived versus recombinant factor VIII concentrates: A critical systematic review
- (2011) Massimo Franchini et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A
- (2011) K. Fischer et al. HAEMATOLOGICA
- Concentrate-related inhibitor risk: is a difference always real?
- (2011) A. IORIO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Can B-domain deletion alter the immunogenicity of recombinant factor VIII? A meta-analysis of prospective clinical studies
- (2011) L. M. ALEDORT et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Factor VIII inhibitors in previously treated hemophilic patients
- (2011) P. M. MANNUCCI JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management
- (2011) L. A. VALENTINO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment
- (2010) B. Mei et al. BLOOD
- Origin of mutation in sporadic cases of haemophilia-B
- (2010) Stefan Kling et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- von Willebrand factor: what is its role in the immune response in haemophilia?
- (2010) S. KAVERI et al. HAEMOPHILIA
- Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia
- (2010) P. W. COLLINS et al. HAEMOPHILIA
- Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review
- (2010) A. IORIO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Endothelial Cell Processing and Alternatively Spliced Transcripts of Factor VIII: Potential Implications for Coagulation Cascades and Pulmonary Hypertension
- (2010) Claire L. Shovlin et al. PLoS One
- Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices
- (2009) C. E. WALSH et al. HAEMOPHILIA
- New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development
- (2009) K. KURNIK et al. HAEMOPHILIA
- Inhibitor development: patient-determined risk factors
- (2009) J. ASTERMARK HAEMOPHILIA
- The molecular mechanisms of immunomodulation and tolerance induction to factor VIII
- (2009) B. WATERS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Inhibitors of Factor VIII in Black Patients with Hemophilia
- (2009) Kevin R. Viel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients
- (2009) Kathelijn Fischer et al. PLoS One
- Assessment of Treatment Practice Patterns for Severe Hemophilia A: A Global Nurse Perspective
- (2008) Kate Khair et al. ACTA HAEMATOLOGICA
- Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A
- (2008) S. Lacroix-Desmazes et al. BLOOD
- Effects of secondary prophylaxis started in adolescent and adult haemophiliacs
- (2008) A. TAGLIAFERRI et al. HAEMOPHILIA
- The role of VWF in the immunogenicity of FVIII
- (2008) Sébastien Lacroix-Desmazes et al. THROMBOSIS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now